ANNALS OF NUCLEAR MEDICINE

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

ANNALS OF NUCLEAR MEDICINE

ANN NUCL MED

ISSN / eISSN

0914-7187 / 1864-6433

目标和范围

Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine.

The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.

研究方向

核医学

CiteScore

4.20

查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - Radiology, Nuclear Medicine and Imaging	Q2	#114/312

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING - SCIE	Q3

H-index

出版国家或地区

JAPAN

出版商

Springer Singapore

出版周期

Bimonthly

出版年份

1987

年文章数

107

Open Access

通讯方式

SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

同领域相关热门期刊
近期发表文章

A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy: (2023) Shamim Ahmed Shamim, Naresh Kumar, Geetanjali Arora, Sahil Jaswal, Shalimar, Shivanand Gamanagatti, Chandrasekhar Bal

[18F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer’s disease using a dynamic autoradiography technique: (2023) Hiroko Maruyama, Misaki Gomi, Thet-Thet Lwin, Akio Yoneyama, Toru Sasaki

Response to the letter to the editor: (2023) Shunsuke Yuge, Kanae K. Miyake, Masako Kataoka, Yuji Nakamoto

Current status and perspectives of nuclear cardiology: (2023) Nagara Tamaki, Osamu Manabe

Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy: (2023) Kerstin Michalski, Aleksander Kosmala, Rudolf A. Werner, Sebastian E. Serfling, Anna K. Seitz, Constantin Lapa, Andreas K. Buck, Philipp E. Hartrampf

Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects: (2023) Yuji Nakamoto, Shingo Baba, Hayato Kaida, Osamu Manabe, Tomoya Uehara

High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: (2023) Akira Makino, Kyo Kume, Tetsuya Mori, Tetsuya Tsujikawa, Tatsuya Asai, Hidehiko Okazawa, Yasushi Kiyono

Difference in arterial FDG accumulation in healthy study participants between digital PET/CT and standard PET/CT: (2023) Noriko Nitta, Rika Yoshimatsu, Hitomi Iwasa, Kousuke Nakaji, Kana Miyatake, Miki Nishimori, Tomohiro Matsumoto, Tomoaki Yamanishi, Takuji Yamagami

Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images: (2023) Kenichi Nakajima, Hideyuki Miyauchi, Ken-ichi Hirano, Shinichiro Fujimoto, Michitomo Kawahito, Takashi Iimori, Takashi Kudo

Performance of deep learning models for response evaluation on whole-body bone scans in prostate cancer: (2023) Sangwon Han, Jungsu S. Oh, Seung Yeon Seo, Jong Jin Lee

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

Review of the submission, submitted on 26th April 2021. Received opinions from 2 reviewers on 19th May, and it took until 9th June to make the revisions. It was notified as accepted on 22nd June, proofread on 24th June, and published online directly on 28th June. It is evident that the speed is related to the interest of the editors and reviewers in the manuscript's theme.

2021-11-05

查看所有评论

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.